The company has allotted 7,40,000 equity shares of Rs. 10/- each at a premium of Rs. 35/- (total issue price of Rs. 45/-) on conversion of warrants on preferential basis.
Announcement under Regulation 30 (LODR)-Allotment
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vivo Bio Tech Ltd. on 6ix
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Feb 24 2025
- Vivo Bio Tech Ltd. Press Release Feb 21 2025
- Vivo Bio Tech Ltd. Press Release Feb 20 2025
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Vivo Bio Tech Ltd. Press Release Feb 07 2025
Later from Vivo Bio Tech
- Update Of Convertible Equity Warrants
- Vivo Bio Tech Ltd. Press Release Mar 05 2025
- Vivo Bio Tech Ltd. Press Release Mar 07 2025
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech